Xin Yu

4.3k citations
147 papers · 3.1k indexed · h-index 30
Topics
Cancer Immunotherapy and Biomarkers (17 papers)Lung Cancer Treatments and Mutations (13 papers)Surface Chemistry and Catalysis (12 papers)

In The Last Decade

Xin Yu

131 papers receiving 3.0k citations

Peers

Xin Yu
Comparison fields: 5 of 138
  • Molecular Biology 1.1k
  • Oncology 744
  • Cancer Research 575
  • Biomedical Engineering 353
  • Surgery 335
Replace Sven Hermann with:
Sven Hermann Germany
Tao Li China
Zu-Xi Yu United States
Xingang Li China
Xu Wu United States
Wei Xing China
Jürgen Kopitz Germany
Stanko Skrtic Sweden
Wei Hua China
Kathrin Geiger Germany
Xin Yu relative to Sven Hermann Germany Sven Hermann's profile →
Citations per field
00.5×
Sven Hermann · 1×
Citations per year

Countries citing papers authored by Xin Yu

Since Specialization
Citations

This map shows the geographic impact of Xin Yu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xin Yu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xin Yu more than expected).

Fields of papers citing papers by Xin Yu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xin Yu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xin Yu. The network helps show where Xin Yu may publish in the future.

Co-authorship network of co-authors of Xin Yu

This figure shows the co-authorship network connecting the top 25 collaborators of Xin Yu. A scholar is included among the top collaborators of Xin Yu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xin Yu. Xin Yu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 0
2 1
3 0
4 10
5 3
6 6
7 30
8 44
9 12
10 18
11 18
12 23
13 1
14 79
15 56
16 15
17 10
18 30
19
End-to-end quality adaptation scheme based on QoE prediction for video streaming service in LTE networks
13
20
An extended dynamical solvation shell around proteins.
4

About Xin Yu

Xin Yu is a scholar working on Oncology, Ophthalmology and Equine, having authored 147 papers that have together received 3.1k indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (17 papers), Lung Cancer Treatments and Mutations (13 papers) and Surface Chemistry and Catalysis (12 papers). The work is most often cited by research in Developmental Neuroscience (166 citations), Cancer Research (575 citations) and Critical Care and Intensive Care Medicine (189 citations). Xin Yu has collaborated with scholars based in China, United States and Hong Kong. Frequent co-authors include Zheng Li, Carl A. Doige, Frances J. Sharom, William Ka Kei Wu, Matthew T.V. Chan, Joseph W.K. Chu, Jianxiong Shen, Jianxiong Shen, Gang Chen and Piao Zhang. Their work appears in journals such as Proceedings of the National Academy of Sciences, Journal of the American Chemical Society and Journal of Biological Chemistry.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026